2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal|2022Cited by 2.7k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetesNikolaus Marx, Konstantinos C. Koskinas, Riccardo Asteggiano et al.|European Heart Journal|2023Cited by 1.4k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal - Cardiovascular Imaging|2022Cited by 486
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)Jelena Čelutkienė, Alexander R Lyon, Radek Pudil et al.|European Journal of Heart Failure|2020Cited by 364
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE studyTadafumi Sugimoto, Patrizio Lancellotti, Raluca Dulgheru et al.|European Heart Journal - Cardiovascular Imaging|2017Cited by 348